Enovis Gross Margin 2010-2024 | ENOV
Enovis Gross Margin Historical Data | |||
---|---|---|---|
Date | TTM Revenue | TTM Gross Profit | Gross Margin |
2024-09-30 | $2.00B | $1.14B | 56.82% |
2024-06-30 | $1.91B | $1.09B | 57.16% |
2024-03-31 | $1.82B | $1.05B | 57.92% |
2023-12-31 | $1.71B | $0.99B | 57.96% |
2023-09-30 | $1.66B | $0.96B | 57.64% |
2023-06-30 | $1.63B | $0.93B | 57.19% |
2023-03-31 | $1.59B | $0.90B | 56.40% |
2022-12-31 | $1.56B | $0.87B | 55.66% |
2022-09-30 | $0.99B | $0.65B | 65.58% |
2022-06-30 | $0.96B | $0.63B | 65.35% |
2022-03-31 | $0.92B | $0.61B | 66.49% |
2021-12-31 | $1.43B | $0.78B | 54.56% |
2021-09-30 | $0.47B | $0.44B | 93.02% |
2021-06-30 | $0.92B | $0.59B | 63.76% |
2021-03-31 | $1.18B | $0.63B | 52.92% |
2020-12-31 | $1.12B | $0.60B | 53.84% |
2020-09-30 | $3.13B | $1.33B | 42.46% |
2020-06-30 | $3.17B | $1.35B | 42.67% |
2020-03-31 | $3.46B | $1.49B | 43.01% |
2019-12-31 | $3.33B | $1.40B | 42.10% |
2019-09-30 | $2.67B | $1.10B | 41.28% |
2019-06-30 | $2.34B | $0.90B | 38.57% |
2019-03-31 | $2.00B | $0.72B | 36.07% |
2018-12-31 | $2.19B | $0.73B | 33.29% |
2018-09-30 | $1.48B | $0.54B | 36.83% |
2018-06-30 | $1.80B | $0.64B | 35.43% |
2018-03-31 | $2.09B | $0.70B | 33.72% |
2017-12-31 | $1.94B | $0.67B | 34.67% |
2017-09-30 | $3.01B | $0.93B | 31.01% |
2017-06-30 | $2.93B | $0.91B | 30.95% |
2017-03-31 | $3.04B | $0.95B | 31.25% |
2016-12-31 | $3.19B | $0.99B | 31.14% |
2016-09-30 | $3.13B | $0.97B | 31.09% |
2016-06-30 | $3.33B | $1.03B | 30.94% |
2016-03-31 | $3.40B | $1.06B | 31.12% |
2015-12-31 | $3.43B | $1.07B | 31.19% |
2015-09-30 | $4.11B | $1.31B | 31.87% |
2015-06-30 | $4.31B | $1.39B | 32.21% |
2015-03-31 | $4.48B | $1.45B | 32.30% |
2014-12-31 | $4.62B | $1.48B | 31.99% |
2014-09-30 | $4.59B | $1.44B | 31.47% |
2014-06-30 | $4.44B | $1.39B | 31.34% |
2014-03-31 | $4.31B | $1.34B | 31.08% |
2013-12-31 | $4.21B | $1.31B | 31.04% |
2013-09-30 | $4.06B | $1.26B | 30.94% |
2013-06-30 | $4.00B | $1.23B | 30.61% |
2013-03-31 | $3.97B | $1.20B | 30.25% |
2012-12-31 | $3.91B | $1.15B | 29.47% |
2012-09-30 | $3.06B | $0.91B | 29.60% |
2012-06-30 | $2.28B | $0.68B | 29.82% |
2012-03-31 | $1.42B | $0.43B | 30.26% |
2011-12-31 | $0.69B | $0.24B | 34.73% |
2011-09-30 | $0.68B | $0.24B | 34.99% |
2011-06-30 | $0.65B | $0.23B | 34.88% |
2011-03-31 | $0.58B | $0.20B | 34.94% |
2010-12-31 | $0.54B | $0.19B | 35.42% |
2010-09-30 | $0.51B | $0.18B | 35.38% |
2010-06-30 | $0.50B | $0.18B | 35.39% |
2010-03-31 | $0.51B | $0.18B | 35.36% |
2009-12-31 | $0.53B | $0.19B | 35.43% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $2.529B | $1.707B |
Enovis Corporation is a medical technology company. Its range of products, services and integrated technologies fuel active lifestyles in orthopedics and beyond. Enovis Corporation, formerly known as Colfax Corporation, is based in Wilmington, DE. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Tempus AI (TEM) | United States | $8.497B | 0.00 |
Inspire Medical Systems (INSP) | United States | $5.276B | 164.53 |
Hims & Hers Health (HIMS) | United States | $5.141B | 130.72 |
Privia Health (PRVA) | United States | $2.533B | 211.10 |
IRhythm Technologies (IRTC) | United States | $2.362B | 0.00 |
Azenta (AZTA) | United States | $2.001B | 99.78 |
Omnicell (OMCL) | United States | $1.964B | 64.26 |
Clover Health Investments (CLOV) | United States | $1.644B | 0.00 |
10x Genomics (TXG) | United States | $1.643B | 0.00 |
Schrodinger (SDGR) | United States | $1.378B | 0.00 |
Phreesia (PHR) | United States | $1.072B | 0.00 |
Butterfly Network (BFLY) | United States | $0.650B | 0.00 |
Standard BioTools (LAB) | United States | $0.562B | 0.00 |
Talkspace (TALK) | United States | $0.522B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.520B | 0.00 |
Definitive Healthcare (DH) | United States | $0.483B | 83.60 |
Health Catalyst (HCAT) | United States | $0.459B | 0.00 |
TruBridge (TBRG) | United States | $0.244B | 71.22 |
Pulmonx (LUNG) | United States | $0.237B | 0.00 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.214B | 0.00 |
American Well (AMWL) | United States | $0.122B | 0.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.107B | 0.00 |
P3 Health Partners (PIII) | United States | $0.075B | 0.00 |
HeartBeam (BEAT) | United States | $0.067B | 0.00 |
111 (YI) | China | $0.053B | 0.00 |
CareCloud (CCLD) | United States | $0.046B | 0.00 |
Zepp Health (ZEPP) | China | $0.040B | 0.00 |
SHL Telemedicine (SHLT) | Israel | $0.040B | 0.00 |
Outset Medical (OM) | United States | $0.039B | 0.00 |
Movano (MOVE) | United States | $0.020B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.019B | 0.00 |
Streamline Health Solutions (STRM) | United States | $0.014B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.013B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.012B | 0.00 |
MSP Recovery (LIFW) | United States | $0.010B | 0.00 |
Precipio (PRPO) | United States | $0.009B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
Mobile-health Network Solutions (MNDR) | Singapore | $0.006B | 0.00 |
Predictive Oncology (POAI) | United States | $0.004B | 0.00 |
Syra Health (SYRA) | United States | $0.004B | 0.00 |
HeartSciences (HSCS) | United States | $0.002B | 0.00 |
Zhongchao (ZCMD) | China | $0.002B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
Future Health ESG (FHLT) | United States | $0.000B | 0.00 |
MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |